Renaissance Technologies’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-444,800
| Closed | -$667K | – | 4417 |
|
|
2023
Q1 | $667K | Sell |
444,800
-248,486
| -36% | -$373K | ﹤0.01% | 2717 |
|
|
2022
Q4 | $692K | Sell |
693,286
-13,614
| -2% | -$13.6K | ﹤0.01% | 2748 |
|
|
2022
Q3 | $1.27M | Sell |
706,900
-44,400
| -6% | -$79.9K | ﹤0.01% | 2352 |
|
|
2022
Q2 | $2.18M | Sell |
751,300
-691,300
| -48% | -$2M | ﹤0.01% | 2118 |
|
|
2022
Q1 | $3.98M | Buy |
1,442,600
+550,700
| +62% | +$1.52M | ﹤0.01% | 1753 |
|
|
2021
Q4 | $4.16M | Buy |
891,900
+698,100
| +360% | +$3.25M | 0.01% | 1647 |
|
|
2021
Q3 | $1.65M | Buy |
193,800
+32,400
| +20% | +$276K | ﹤0.01% | 2237 |
|
|
2021
Q2 | $2.65M | Buy |
161,400
+12,900
| +9% | +$212K | ﹤0.01% | 2061 |
|
|
2021
Q1 | $3.28M | Buy |
+148,500
| New | +$3.28M | ﹤0.01% | 1916 |
|
|
2020
Q4 | – | Sell |
-67,700
| Closed | -$1.38M | – | 3817 |
|
|
2020
Q3 | $1.38M | Buy |
67,700
+33,600
| +99% | +$683K | ﹤0.01% | 2329 |
|
|
2020
Q2 | $524K | Sell |
34,100
-17,200
| -34% | -$264K | ﹤0.01% | 2857 |
|
|
2020
Q1 | $397K | Buy |
+51,300
| New | +$397K | ﹤0.01% | 2870 |
|